Home
Arbor Pharmaceuticals

Arbor Pharmaceuticals Market Share Analysis for July 2026

Azurity Pharmaceuticals welcomes our web site users. Please read the Terms of Use before using or submitting information on any of our web sites.

Health > Biotechnology and Pharmaceuticals

Domainarborpharma.com

Year Founded2006

Employees201 - 500

Annual Revenue$100M - $200M

Arbor Pharmaceuticals

Arbor Pharmaceuticals (including company regionals)

arborpharma.com

See more website traffic and engagement information

Arbor Pharmaceuticals Revenue up to July 2026 is 100M - 200M

revenue generated by Arbor Pharmaceuticals top domains

Arbor Pharmaceuticals top domains revenue over 3 years

Revenue for Arbor Pharmaceuticals top domains

arborpharma.com100M - 200M

See more with Sales Intelligence

Total visits to Arbor Pharmaceuticals's top domains

Understand Arbor Pharmaceuticals market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Arbor Pharmaceuticals's top domains

Analyze Arbor Pharmaceuticals engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Arbor Pharmaceuticals's top domains

See how Arbor Pharmaceuticals keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Arbor Pharmaceuticals top competitors by domain

Top similar sites in July 2026, ranked by their affinity

concertpharma.comCompany NameConcert PharmaceuticalsEmployees51 - 200HQUnited States, Massachusetts, LexingtonAnnual revenue< $1MTotal visits--Health > Biotechnology and Pharmaceuticals

Top technologies used by Arbor Pharmaceuticals

These are the website technologies, by industry, used by Arbor Pharmaceuticals top domains

Payment & Currencies (8)

Cart Functionality

Advertising (5)

Google Adsense

Widget (5)

Twemoji

Conversion & Analytics (2)

Google Analytics

More Technologies

7

See all

News & Signals from Arbor Pharmaceuticals

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsArborpharma acquires XenoPort, Inc..Shortly after his tenure, XenoPort was acquired by Arbor Pharmaceuticals, LLC.

NewsAzurity Pharmaceuticals, Inc. acquired Arborpharma on Aug 24th '21.Azurity Pharmaceuticals, Inc. (“Azurity”) and Arbor Pharmaceuticals, Inc. (“Arbor”) today announced they have entered into a definitive agreement in which Azurity will be acquiring Arbor from existing investors including JW Asset Management and KKR.

NewsArborpharma recognized as marketing of T89 in the States on Sep 6th '18.Tasly Pharmaceutical Group Co., Ltd. (referred to as “Tasly”) and the US-based drug maker Arbor Pharmaceuticals, Inc. (referred to as “Arbor”) announced on Sep. 6 comprehensive cooperation in the R&D and marketing of T89 in the States.